Rashmi Raghavendra is the CEO of Dionysus Health, a precision diagnostics company that is making a test that predicts the likelihood of a woman developing postpartum depression. In this episode, Rashmi discusses how postpartum depression and psychosis have dominated the headlines recently in light of the Lindsay Clancy trial.
She also details her company's groundbreaking new postpartum depression tests and what that could mean for the future of treatment options for parents who are experiencing these symptoms.
Want to learn more about women's health? Attend the Formidable Women's Health Summit on October 30th, 2026. Full details at: beformidable.com/womenshealth
